JEA YOO: Open Payments
NPI 1245828946 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$422 in 18 payments from 9 companies in 2025. Trend: 2023 $4,471 · 2024 $3,978 · 2025 $422
Food & beverage: $422
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $103 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Neurocrine BioSciences, Inc. | 2 | $61 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Teva Pharmaceuticals USA, Inc. | 2 | $44 |
| Lundbeck LLC | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Noven Therapeutics, LLC | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: REXULTI, VRAYLAR, INGREZZA, FANAPT, AUSTEDO XR, COBENFY, Xelstrym, TRINTELLIX.
Industry payments across CA — which companies pay providers there.
